Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Risperidone Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112794849A reveals a green synthesis for risperidone intermediates, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN112624992B reveals a purification breakthrough for risperidone intermediates. Achieve 99.9% purity and stable supply chain for API manufacturing.
Patent CN1720228A details a novel acetate salt method for enriching Z-oxime intermediates, enhancing yield and purity for reliable pharmaceutical intermediates supply chains.
Patent CN112794849B details a novel, eco-friendly route to 3-(2-chloroethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, eliminating toxic POCl3 and enhancing supply chain stability.
Novel green synthesis of risperidone intermediate avoiding POCl3. High yield, scalable process for reliable pharmaceutical intermediate supply.